DB05842ExperimentalSmall molecule
AI-850 is a Cremophor(R)-free formulation of paclitaxel, the active ingredient in Taxol(R), a product used to treat a variety of solid tumors.
- Mechanism
- Curator reviewed
AI-850 utilizes Hydrophobic Drug Delivery System or HDDDsTechnology. It is readily dissolving formulation of the hydrophobic drug, paclitaxel, the active ingredient in the cancer drug, Taxol.
- Primary indication
- Investigated for use/treatment in breast cancer and solid tumors.Curator reviewed
- Code names
- AI-850
What you can answer from here — as of April 02, 2025
Which companies are running trials of AI-850, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account